1. Aberrant Hypermethylation-Mediated Suppression of PYCARD Is Extremely Frequent in Prostate Cancer with Gleason Score ≥ 7. (4th February 2021) Authors: Miyauchi, Toshiya; Takahashi, Masahiro; Mitsuzuka, Koji; Saiki, Yuriko; Okubo, Teppei; Vertino, Paula M.; Goto, Akiteru; Arai, Yoichi; Horii, Akira; Fukushige, Shinichi Other Names: Miyamoto Hiroshi Academic Editor. Journal: Disease markers Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical significance of the LacdiNAc‐glycosylated prostate‐specific antigen assay for prostate cancer detection. Issue 8 (27th June 2019) Authors: Yoneyama, Tohru; Tobisawa, Yuki; Kaneko, Tomonori; Kaya, Takatoshi; Hatakeyama, Shingo; Mori, Kazuyuki; Sutoh Yoneyama, Mihoko; Okubo, Teppei; Mitsuzuka, Koji; Duivenvoorden, Wilhelmina; Pinthus, Jehonathan H.; Hashimoto, Yasuhiro; Ito, Akihiro; Koie, Takuya; Suda, Yoshihiko; Gardiner, Robert A.;... Journal: Cancer science Issue: Volume 110:Issue 8(2019) Page Start: 2573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Systemic treatment for coexisting mucinous urethral adenocarcinoma and prostate adenocarcinoma. Issue 6 (2nd August 2020) Authors: Nezu, Kunihisa; Okubo, Teppei; Shiraiwa, Manabu; Nozawa, Yoshihiro; Kyan, Atsushi Journal: IJU case reports Issue: Volume 3:Issue 6(2020) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗